Department of Molecular and Integrative Physiology, University of Kansas Medical Center , Kansas City, Kansas.
Kansas City Veterans Affairs Medical Center , Kansas City, Kansas.
Am J Physiol Endocrinol Metab. 2019 Aug 1;317(2):E298-E311. doi: 10.1152/ajpendo.00098.2019. Epub 2019 Apr 30.
The impact of sexual dimorphism and mitophagy on hepatic mitochondrial adaptations during the treatment of steatosis with physical activity are largely unknown. Here, we tested if deficiencies in liver-specific peroxisome proliferative activated-receptor-γ coactivator-1α (PGC-1α), a transcriptional coactivator of biogenesis, and BCL-2/ADENOVIRUS EIB 19-kDa interacting protein (BNIP3), a mitophagy regulator, would impact hepatic mitochondrial adaptations (respiratory capacity, HO production, mitophagy) to a high-fat diet (HFD) and HFD plus physical activity via voluntary wheel running (VWR) in both sexes. Male and female wild-type (WT), liver-specific PGC-1α heterozygote (LPGC-1α), and BNIP3 null mice were thermoneutral housed (29-31°C) and divided into three groups: sedentary-low-fat diet (LFD), 16 wk of (HFD), or 16 wk of HFD with VWR for the final 8 wk (HFD + VWR) ( = 5-7/sex/group). HFD did not impair mitochondrial respiratory capacity or coupling in any group; however, HFD + VWR significantly increased maximal respiratory capacity only in WT and PGC-1α females. Males required VWR to elicit mitochondrial adaptations that were inherently present in sedentary females including greater mitochondrial coupling control and reduced HO production. Females had overall reduced markers of mitophagy, steatosis, and liver damage. Steatosis and markers of liver injury were present in sedentary male mice on the HFD and were effectively reduced with VWR despite no resolution of steatosis. Overall, reductions in PGC-1α and loss of BNIP3 only modestly impacted mitochondrial adaptations to HFD and HFD + VWR with the biggest effect seen in BNIP3 females. In conclusion, hepatic mitochondrial adaptations to HFD and treatment of HFD-induced steatosis with VWR are more dependent on sex than PGC-1α or BNIP3.
性二态性和线粒体自噬对运动治疗脂肪变性过程中肝线粒体适应性的影响在很大程度上是未知的。在这里,我们测试了肝脏特异性过氧化物酶体增殖物激活受体-γ共激活因子-1α(PGC-1α)的缺乏,作为生物发生的转录共激活因子,和 BCL-2/腺病毒 EIB 19-kDa 相互作用蛋白(BNIP3),一种线粒体自噬调节剂,是否会影响高脂肪饮食(HFD)和 HFD 加体力活动(通过自愿轮跑(VWR))对两性的肝线粒体适应性(呼吸能力、HO 产生、线粒体自噬)。雄性和雌性野生型(WT)、肝脏特异性 PGC-1α 杂合体(LPGC-1α)和 BNIP3 缺失小鼠在热中性环境(29-31°C)中饲养,并分为三组:久坐低脂饮食(LFD)、16 周 HFD 或 16 周 HFD 加 VWR 最后 8 周(HFD+VWR)(=5-7/性别/组)。HFD 并未损害任何组的线粒体呼吸能力或偶联;然而,HFD+VWR 仅在 WT 和 PGC-1α 雌性中显著增加最大呼吸能力。雄性需要 VWR 才能引起静息雌性固有存在的线粒体适应性,包括更大的线粒体偶联控制和减少 HO 产生。雌性总体上减少了线粒体自噬、脂肪变性和肝损伤的标志物。在 HFD 上,久坐的雄性小鼠存在脂肪变性和肝损伤标志物,尽管脂肪变性没有得到解决,但 VWR 可有效减少这些标志物。总体而言,PGC-1α 的减少和 BNIP3 的缺失仅适度影响 HFD 和 HFD+VWR 对线粒体的适应性,而 BNIP3 雌性的影响最大。总之,HFD 对肝线粒体的适应性和 VWR 对 HFD 诱导的脂肪变性的治疗更多地依赖于性别而不是 PGC-1α 或 BNIP3。